Q32 Bio Inc (NASDAQ: QTTB) Plunged -28.57%, So What Now?

Q32 Bio Inc (NASDAQ:QTTB) shares, rose in value on Thursday, December 12, with the stock price down by -28.57% to the previous day’s close as strong demand from buyers drove the stock to $4.25.

Actively observing the price movement in the last trading, the stock closed the session at $5.95, falling within a range of $4.1701 and $5.9679. Referring to stock’s 52-week performance, its high was $53.79, and the low was $5.80. On the whole, QTTB has fluctuated by -90.27% over the past month.

With the market capitalization of Q32 Bio Inc currently standing at about $51.77 million, investors are eagerly awaiting this quarter’s results, scheduled for in January.

Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that QTTB’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of Hold while long-term indicators on average have been pointing out that it is a 50% Sell.

The stock’s technical analysis shows that the price of QTTB currently trading nearly -82.83% and -88.80% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 15.85, while the 7-day volatility ratio is showing 29.40% which for the 30-day chart, stands at 15.83%. Furthermore, Q32 Bio Inc (QTTB)’s beta value is -0.47, and its average true range (ATR) is 4.29.

A comparison of Q32 Bio Inc (QTTB) with its peers suggests the former has fared considerably weaker in the market. QTTB showed an intraday change of -28.57% in last session, and over the past year, it shrunk by -55.86%%.

Data on historical trading for Q32 Bio Inc (NASDAQ:QTTB) indicates that the trading volumes over the past 10 days have averaged 0.47 and over the past 3 months, they’ve averaged 161.70K. According to company’s latest data on outstanding shares, there are 12.14 million shares outstanding.

Nearly 61.97% of Q32 Bio Inc’s shares belong to company insiders and institutional investors own 31.78% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.72 million shares as on 2024-11-29, resulting in a short ratio of 6.74. The stock has fallen by -61.17% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the QTTB stock heading into the next quarter.

Most Popular